Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions
This study has been completed.
Study NCT00778245   Information provided by Ranbaxy Inc.

First Received on October 22, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
cefprozil 500mg tablets
Additional drug interventions recognized in this trial
Cefprozil
Cephalosporins
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Ranbaxy Laboratories Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services